Teijin

Teijin is a Japanese kabushiki gaisha specializing in the chemical, medical device, oxygen concentrator, bioplastic, healthcare, and pharmaceutical industries. The company was founded on June 17, 1918 and is headquartered in Osaka and Tokyo, Japan. Teijin operates with a B2B business model and focuses on commerce. The company's CEO is Jun Suzuki.

Teijin has several competitors, including Covestro, Kuraray, Asahi Kasei, Toray Industries, Toyobo, and Kaneka. Teijin is listed on the Tokyo Stock Exchange and trades under the stock symbol 3401. The company has assigned 329 patents.

Teijin has an active company status and employs between 10,000 and 49,999 people, with a total of 16,819 employees reported. The full address of the company's headquarters is Kasumigaseki Common Gate West Tower, 2-1, Kasumigaseki 3-chome, Chiyoda-ku, Tokyo 100-8585, Japan.